Limb graft occlusion after endovascular aneurysm repair with the Cook Zenith Alpha abdominal graft

Magdalena Broda1, Jonas Eiberg2, Mikkel Taudorf3

  • 1Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Insights

The Zenith Alpha graft showed a 7% limb graft occlusion (LGO) rate within 3 years. Contrary to expectations, calcified iliac arteries were found to be protective against LGO.

Area of Science:

  • Vascular Surgery
  • Endovascular Aneurysm Repair
  • Medical Device Performance

Background:

  • The Zenith Alpha abdominal graft has reported issues with limb graft patency, leading to reinterventions.
  • Manufacturer notices suggest Instructions for Use (IFU) violations contribute to these complications.
  • Understanding anatomical risk factors for limb graft occlusion (LGO) is crucial for improving outcomes.

Purpose of the Study:

  • To assess the incidence of LGO in patients receiving the Zenith Alpha graft.
  • To analyze the association between detailed anatomical risk factors and LGO.
  • To evaluate the protective effect of iliac artery calcification on LGO.

Main Methods:

  • Retrospective analysis of 241 patients treated with the Zenith Alpha graft.
  • Computed tomography angiograms analyzed using 3D software.
  • Regression analysis to identify risk factors for LGO, including vessel diameters, graft oversizing, iliac tortuosity/calcification, and sealing zones.

Main Results:

  • A cumulative incidence of 7% LGO was observed per limb up to 3 years postoperatively.
  • No previously identified risk factors were positively associated with LGO.
  • Heavily calcified common and external iliac arteries demonstrated a protective effect against LGO.

Conclusions:

  • The Zenith Alpha graft has a 7% LGO incidence within 3 years.
  • Identified anatomical risk factors did not correlate with increased LGO.
  • Iliac artery calcification appears to be a protective factor against LGO.
Abstract